These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8270079)

  • 1. Cross-linked fibrin degradation products (XL-FDP) as marker of early rethrombosis in percutaneous transluminal angioplasty.
    Jørgensen B; Nielsen JD; Nørgård J; Helligsø P; Baekgaard N; Egeblad M
    Eur J Vasc Surg; 1993 Nov; 7(6):720-4. PubMed ID: 8270079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombosis and intrinsic fibrinolysis in percutaneous transluminal angioplasty.
    Jørgensen B; Nielsen JD; Helligsø P; Baekgaard N; Egeblad M
    Eur J Vasc Surg; 1994 May; 8(3):264-9. PubMed ID: 8013675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early rethrombosis in femoropopliteal occlusions treated with percutaneous transluminal angioplasty.
    Jørgensen B; Meisner S; Holstein P; Tønnesen KH
    Eur J Vasc Surg; 1990 Apr; 4(2):149-52. PubMed ID: 2140988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial thrombin activity produced by percutaneous transluminal angioplasty eliminated by segmentally enclosed thrombolysis.
    Jørgensen B; Nielsen JD
    Eur J Vasc Surg; 1992 Mar; 6(2):153-7. PubMed ID: 1533371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Doppler sonography diagnosis of restenosis after percutaneous transluminal angioplasty: sensitivity and specificity of the pedal-brachial index in relation to changes in absolute arterial blood pressure].
    Radak Dj; Laps KH; Jeger KA; Ilijevski N; Vojić M
    Srp Arh Celok Lek; 1998; 126(3-4):83-91. PubMed ID: 9863361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmentally enclosed thrombolysis in percutaneous transluminal angioplasty for femoropopliteal occlusions: a report from a pilot study.
    Jørgensen B; Tønnesen KH; Nielsen JD; Holstein P; Bülow J; Jørgensen M; Andersen E
    Cardiovasc Intervent Radiol; 1991; 14(5):293-8. PubMed ID: 1834337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doppler-based diagnosis of restenosis after femoropopliteal percutaneous transluminal angioplasty: sensitivity and specificity of the ankle/brachial pressure index versus changes in absolute pressure values.
    Radak D; Labs KH; Jäger KA; Bojić M; Popović AD
    Angiology; 1999 Feb; 50(2):111-22. PubMed ID: 10063941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
    Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous transluminal angioplasty and enclosed thrombolysis versus percutaneous transluminal angioplasty in the treatment of femoropopliteal occlusions: results of a prospective randomized trial.
    Nicholson T
    Cardiovasc Intervent Radiol; 1998; 21(6):470-4. PubMed ID: 9853164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
    Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous revascularization of femoropopliteal artery disease: PTA and PTA plus stent. Results after six years' follow-up.
    Pozzi Mucelli F; Fisicaro M; Calderan L; Malacrea M; Mazzone C; Cattin L; Scardi S; Pozzi Mucelli R
    Radiol Med; 2003 Apr; 105(4):339-49. PubMed ID: 12835627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous angioplasty and stenting of the superficial femoral artery.
    Surowiec SM; Davies MG; Eberly SW; Rhodes JM; Illig KA; Shortell CK; Lee DE; Waldman DL; Green RM
    J Vasc Surg; 2005 Feb; 41(2):269-78. PubMed ID: 15768009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries.
    Karch LA; Mattos MA; Henretta JP; McLafferty RB; Ramsey DE; Hodgson KJ
    J Vasc Surg; 2000 May; 31(5):880-7. PubMed ID: 10805877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation.
    Schillinger M; Haumer M; Schlerka G; Mlekusch W; Exner M; Ahmadi R; Minar E
    J Endovasc Ther; 2001 Oct; 8(5):477-83. PubMed ID: 11718406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained fibrinolysis after administration of t-PA despite its short half-life in the circulation.
    Eisenberg PR; Sherman LA; Tiefenbrunn AJ; Ludbrook PA; Sobel BE; Jaffe AS
    Thromb Haemost; 1987 Feb; 57(1):35-40. PubMed ID: 3109058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.
    Laird JR; Schneider PA; Tepe G; Brodmann M; Zeller T; Metzger C; Krishnan P; Scheinert D; Micari A; Cohen DJ; Wang H; Hasenbank MS; Jaff MR;
    J Am Coll Cardiol; 2015 Dec; 66(21):2329-2338. PubMed ID: 26476467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
    Krishnan P; Faries P; Niazi K; Jain A; Sachar R; Bachinsky WB; Cardenas J; Werner M; Brodmann M; Mustapha JA; Mena-Hurtado C; Jaff MR; Holden AH; Lyden SP
    Circulation; 2017 Sep; 136(12):1102-1113. PubMed ID: 28729250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Femoro-popliteal artery occlusions treated by percutaneous transluminal angioplasty and enclosed thrombolysis: results in 55 patients.
    Tønnesen KH; Holstein P; Andersen E
    Eur J Vasc Surg; 1991 Aug; 5(4):429-34. PubMed ID: 1833242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.